Skin cancer cells viewed under a microscope. Such images can reveal how the cancer spreads.Credit: NCI Center for Cancer Research/NCI/SPL The announcement on 19 August that people with melanoma who received a personalized vaccine lived longer without a cancer recurrence than those who didn’t have the vaccine is a sensation for the field. The results
The net worths of CEOs and founders are largely at the whim of their company stock—all it takes is one breakout earnings report or blockbuster news to shake up their fortunes. Now, Moderna cofounder Robert Langer has re-entered the billionaires club following promising cancer vaccine trials that sent the company’s stock soaring. Langer, known as
A cancer vaccine developed by Moderna and Merck reduced the recurrence of melanoma.Credit: Adam Glanzman/Bloomberg/Getty A personalized mRNA vaccine for melanoma reduced the risk of the cancer returning in a phase III clinical trial, the companies behind the trial announced this week. The vaccine — which relies on the same mRNA technology used to develop
